"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Organon","Organon & Co.","$31,000,000","$0","$31,000,000","2014","20141015","healthcare-related offenses","off-label or unapproved promotion of medical products","kickbacks and bribery","Organon agreed to pay $31 million to settle multistate litigation alleging that it offered improper financial incentives to nursing home pharmacy companies, promoted its antidepressants for unapproved uses, and misrepresented its drug prices to Medicaid programs.","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","USA","New Jersey","publicly traded","OGN","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20160820081053/http://ag.ny.gov/press-release/ag-schneiderman-announces-31-million-national-medicaid-settlement-pharmaceutical",""
"Organon USA Inc","Organon & Co.","$36,000,000","$0","$36,000,000","2004","20041021","competition-related offenses","price-fixing or anti-competitive practices","","Organon agreed to pay $36 million to settle multistate litigation alleging that the company improperly tryied to keep the generic equivalent for its drug Remeron off the market.","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","USA","New Jersey","publicly traded","OGN","pharmaceuticals","pharmaceuticals","https://www.atg.wa.gov/news/news-releases/ag-settles-organon",""
"Organon USA Inc.","Organon & Co.","$100,000,000","$0","$100,000,000","2018","20180920","safety-related offenses","drug or medical equipment safety violation","product safety violation","Organon, then a subsidiary of Merck, agreed to pay $100 million to settle multi-district litigation alleging that its NuvaRing birth control device caused fatal blood clots.","federal","private litigation","","civil","","Eastern District of Missouri","4:08-md-01964","In re: NuvaRing Litigation","settlement","","","","","","","USA","New Jersey","publicly traded","OGN","pharmaceuticals","pharmaceuticals","https://www.law360.com/articles/507908/merck-to-pay-100m-to-end-nuvaring-blood-clot-suits",""
